Elevated expression of the cdc25A protein phosphatase in colon cancer

Experimental Cell Research

Volumn 240, Issue 2, 1998, Pages 236-243

  Dixon, Dora ^a   Moyana, Terence ^a   King, Martin J ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Cdc25A; Colon cancer; Mitotic index; Nuclei; Phosphotyrosyl protein phosphatase

Indexed keywords

PHOSPHOPROTEIN PHOSPHATASE;

ANIMAL TISSUE; ARTICLE; COLON CANCER; COLON CARCINOGENESIS; COLON MUCOSA; INTESTINE MUCOSA; MITOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTO ONCOGENE; RAT;

ANIMALIA; SIPROETA STELENES;

EID: 0031853064     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1998.3940     Document Type: Article

References (27)

1. Yarden Y., Ullrich A. Growth factor receptor tyrosine kinases. Annu. Rev. Biochem. 57:1988;443-478.
2. Sefton B. M., Hunter T., Ball E. H., Singer S. J. Vinculin: A cytoskeletal target of the transforming protein of Rous sarcoma virus. Cell. 24:1981;165-174.
3. Diamond R. H., Cressman D. E., Laz T. M., Abrams C. S., Taub R. PRL-1, a unique nuclear protein tyrosine phosphatase, affects cell growth. Mol. Cell. Biol. 14:1994;3752-3762.
4. c-srcby overexpression of a protein tyrosine phosphatase. Nature. 359:1992;336-339.
5. Galaktionov K., Lee A. K., Eckstein J., Draetta G., Meckler J., Loda M., Beach D. CDC25 phosphatases as potential human oncogenes. Science. 269:1995;1575-1577.
6. Klarland J. K. Transformation of cells by an inhibitor of phosphatases acting on phosphotyrosine in proteins. Cell. 41:1985;707-717.
7. Gentleman S., Martensen T. M., Digiovanna J. J., Chader G. J. Protein tyrosine kinase and protein phosphotyrosine phosphatase in normal and psoriatic skin. Biochim. Biophys. Acta. 798:1984;53-59.
8. Wiener J. R., Kerns B.-J. M., Harvey E. L., Conaway M. R., Iglehart C. J. D., Berchuck A., Bast R. C. Overexpression of the protein tyrosine phosphatase PTP1B in human breast cancer: Association with p185c-erbB-2 protein expression. J. Natl. Cancer Inst. 86:1994;372-378.
9. Kidd K. R., Kerns B.-J. O., Dodge R. K., Wiener J. R. Histochemical staining of protein-tyrosine phosphatase activity in primary human mammary carcinoma: Relationship with established prognostic indicators. J. Histochem. Cytochem. 40:1992;729-735.
10. Wiener J. R., Hurteau J. A., Kerns B.-J. M., Whitaker R. S., Conaway M. R., Berchuck A., Bast R. C. Overexpression of the tyrosine phosphatase PTP1B is associated with human ovarian carcinomas. Am. J. Obstet. Gynecol. 170:1994;1177-1183.
11. Zhai Y. F., Beittenmiller H., Wang B., Gould M. N., Oakley C., Esselman W. J., Welsch C. W. Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene. Cancer Res. 53:1993;2272-2278.
12. Matozaki T., Suzuki T., Uchida T., Inazawa J., Ariyama T., Matsuda K., Horita K., Noguchi H., Mizuno H., Sakamoto C., Kasuga M. Molecular cloning of a human transmembrane-type protein tyrosine phosphatase and its expression in gastrointestinal cancers. J. Biol. Chem. 269:1994;2075-2081.
13. Lammers R., Bossenmaier B., Cool D. E., Tonks N. K., Schlessinger J., Fischer E. H., Ullrich A. Differential activities of protein tyrosine phosphatases in intact cells. J. Biol. Chem. 268:1993;22,456-22,462.
14. Brown-Shimer S., Johnson K. A., Hill D. E., Bruskin A. M. Effect of protein tyrosine phosphatase 1B expression on transformation by the human neu oncogene. Cancer Res. 52:1992;478-482.
15. Ramponi G., Ruggiero M., Raugei G., Berti A., Modesti A., Degl'Innocent D., Magnelli L., Pazzagli C., Chiarugi V. P., Camici G. Overexpression of a synthetic phosphotyrosine protein phosphatase gene inhibits normal and transformed cell growth. Int. J. Cancer. 51:1992;652-656.
16. Berggren M. M., Burns L. A., Abraham R. T., Powls G. Inhibition of protein tyrosine phosphatase by the antitumor agent gallium nitrate. Cancer Res. 53:1993;1862-1866.
17. Ghosh J., Miller R. A. Suramin, an experimental chemotherapeutic drug, irreversibly blocks T cell CD45-protein tyrosine phosphatasein vitro. Biochem. Biophys. Res. Commun. 194:1993;36-44.
18. Chauveau J., Moulé Y., Rouiller C. H. Exp. Cell Res. 11:1956;317.
19. King M. J., Sharma R. K. N-Myristoyl transferase assay using phosphocellulose paper binding. Anal. Biochem. 199:1991;149-153.
20. Harder K. W., Owen P., Wong L. K. H., Aebersold R., Clark-Lewis I., Jirik F. R. Characterisation and kinetic analysis of the intracellular domain of human protein tyrosine phosphatase β (HPTPβ) using synthetic phosphopeptides. Biochem. J. 298:1994;395-401.
21. Cartwright C. A., Coad C. A., Egbert B. M. Elevated c-src tyrosine kinase activity in premalignant epithelia of ulcerative colitis. J. Clin. Invest. 93:1994;509-515.
22. King M. J., Sale G. J. Insulin-receptor phosphotyrosyl-protein phosphatases. Biochem. J. 256:1988;893-902.
23. King M. J. Insulin Receptor Phosphotyrosyl Protein Phosphatases. 1990;University of Southampton.
24. Craven P. A., DeRubertis F. R. Alterations in protein kinase C system of colonic epithelium during fasting-refeeding. Evidence for protein kinase C independent pathway of enhanced proliferative activity. Digestive Diseases Sci. 37:1992;1162-1169.
25. Galaktionov K., Chen X., Beach D. Cdc25 cell-cycle phosphatase as a target of c-myc. Nature. 382:1996;511-517.
26. Pories S. E., Weber T. K., Simpson H., Greathead P., Steele G., Summerhayes I. C. Immortalization and neoplastic transformation of normal rat colon epithelium: An in vitro model for colonic neoplastic progression. Gastroenterology. 104:1993;1346-1355.
27. Tonks N. K., Neel B. G. From form to function: Signalling by protein tyrosine phosphatases. Cell. 87:1996;365-368.